Preclinical biotechnology company
BiPER Therapeutics has raised €1.3M across 1 funding round from 3 investors, most recently a Seed round in Feb 2023. Based in Strasbourg, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-02-14 | Seed | €1.3M |
| Bpifrance,Grand Est region,Wiseed |
| View deal → |
